closing the gaps in care delivery: pharmacists partnering ... · closing the gaps in care delivery:...
TRANSCRIPT
Closing the Gaps in Care Delivery:Pharmacists Partnering with Providers to Reduce Readmissions, Lower Costs, and Improve Quality
©2013 Walgreen Co. All rights reserved.
Logo is interchangeable with ATCO
Moderator: Robert S. London, MD, National Medical Director, Walgreens Katherine Heller, Pharm.D., Vice President, Clinical Solutions- Integrated
Delivery Systems & Patient Services, Walgreens Jacquelyn Paynter, R.N., M.P.H., C.C.M., Executive Director, Care
Management, DeKalb Medical
Heather Kirkham, MPH PhD, Manager, Clinical Outcomes & Analytics, Walgreens
• Introduction• Learning objectives• Pharmacist services targeting quality gaps in transitions
of care• Case study: DeKalb Medical Center• Methodology and outcomes• Q&A Discussion
Agenda
2©2013 Walgreen Co. All rights reserved.
Introduction
3
Moderator: Robert S. London, MD, National Medical Director, Walgreens
©2013 Walgreen Co. All rights reserved.
1. List three categories of barriers to medication adherence potentially contributing readmissions.
2. Identify medication-related gaps in care associated with hospital admissions and readmissions.
3. Learn how specific pharmacy-related components impact an integrated care transition model.
4. Discover why a community pharmacy in a hospital setting can be most effective in reducing readmissions.
Learning objectives
4©2013 Walgreen Co. All rights reserved.
Readmissions cost hospitals, payers and patients
5©2013 Walgreen Co. All rights reserved.
• 6,000,000 consumer visits daily• Driving innovation in wellness, chronic care, infusion,
specialty and online and mobile Rx• More than 8,500 total points of care• More than 8,000 community pharmacies
6©2013 Walgreen Co. All rights reserved.
Walgreens is far more than just your corner drugstore
Walgreens is far more than just your corner drugstore
• Located within 5 miles of 70% of the U.S. population– #1 in flu immunizations– #1 in health testing services– #1 in Drive-through pharmacies– #1 in 24 Hour Pharmacies– #1 in worksite health centers – #1 in health system pharmacies
• 73,000 healthcare professionals
7©2013 Walgreen Co. All rights reserved.
Overview of Walgreens healthcare assets
8©2013 Walgreen Co. All rights reserved.
Hospital System Solutions
National Network of Retail
Pharmacies
Specialty Pharmacy
A Top 3 Specialty Pharmacy with comprehensive and customizable specialty solutions 700 HIV Centers of Excellence
Infusion Services
Retail Clinics
Employer Health Centers
~350 Take Care Health Clinics located in Walgreens stores in19 states + DC ~1500 NPs and 40PAs; every clinic has a collaborating physician
More than 8,000 pharmacies employing 68,000 trusted cliniciansLocated within 3 miles of ~65% of Americans = 6 M customers each day
#1 infusion provider in the nation with 100 sites in 38 states1000-1500 nurses deliver infusions either at home or at our sites
140 Out Patient Pharmacies in major institutions such as Yale and NorthwesternWell Transitions –significantly reduces hospital readmits
350+ On-site health centers at employer locations; 40+ years experience160+ employer clients in 45 states; serving ~10 M employees at work
New provider paradigm to improve outcomes
• Not physician focused, but linked to physicians and patients
• Leverages certified SMEs (NPs and Pharmacists) as “trusted sources of information”
• Regional and national reach
• Focused on metrics that matter
Retail ‐ Existing Retail ‐ Approved
Home Infusion/RT
SpecialtyTake Care Clinics
Take Care WorksitesHospital On‐Sites Mail
9©2013 Walgreen Co. All rights reserved.
Unequalled global access
•Boots international countries: UK, ROI, Thailand, Netherlands, Middle East, Sweden, Norway•Alphega: UK, France, Italy, Spain, Czech republic, Germany, Netherlands, Russia
•Wholesale countries: France, UK, Turkey, Spain, Germany, Russia, The Netherlands, Czech Republic, Norway, Egypt, Lithuania, •Romania, Algeria, Croatia, Bosnia, Serbia, Slovenia, China, Italy, Portugal, Switzerland
•Alliance Boots
10©2013 Walgreen Co. All rights reserved.
Transforming the patient experience: Well Experience Stores
11©2013 Walgreen Co. All rights reserved.
Pharmacist Services Targeting Quality Gaps in Transitions of Care
12
Katherine Heller, Pharm.D., Vice President Clinical Solutions, Walgreens
©2013 Walgreen Co. All rights reserved.
Rate of readmissions
Admissions increased by 55% between 1997 and 2007 in the United States (that’s 4.5% per year).
– Initial focus on hospitals: Quality of inpatient care and length of stay– Community Care Transitions Program: ACOs, PCMH and Medical Neighborhood
Condition% Readmissions Relative
∆ (%)Absolute ∆
(%)2008 2010Medical 16.2 15.9 -1.7% < 0.5%
CHF 21.4 21.1 -1.4 < 0.5AMI 18.7 18.1 -3.2 - 0.6PN 15.3 15.3 <0.5 < 0.5
Surgical 12.7 12.4 -3.0 < 0.5Source: Goodman DC, Fisher ES, Chang C. After Hospitalization: A Dartmouth Report On Readmissions Among Medicare Beneficiaries.February 2013. Robert Wood Johnson Foundation. Available at: http://www.rwjf.org/content/dam/farm/reports/reports/2013/rwjf404178
©2013 Walgreen Co. All rights reserved. 13
Burden of readmissions
• 20% of Medicare beneficiaries readmitted within 30 days of discharge.1
• Readmissions were estimated to cost taxpayers $15 billion in 2004.1
• Readmissions cost Medicare $17.5 billion in inpatient spend alone in 2012.2
1. Jencks, Stephen F., Mark V. Williams, and Eric A. Coleman. “Rehospitalizations among Patients in the Medicare Fee-for-Service Program.” New England Journal of Medicine 2009; 360:1418-28
2. National Medicare Readmission Findings: Recent Data and Trends. 2012. Available at: http://www.academyhealth.org/files/2012/sunday/brennan.pdf
©2013 Walgreen Co. All rights reserved. 14
Patient-specific factors• Age, sex, socioeconomic deprivation, prior health care use, and
specific conditions such as malignancy, progressive heart failure, and a range of comorbidities
Quality of in-hospital care• General quality of hospital care experienced by the patient and patient
climate
Quality of discharge planning/follow-up care• Presence and adequacy of discharge planning, level of appropriate
outpatient and community care, the degree of patient and family education, and how frequently the patient meets with their physician after discharge
Risk for readmissions
15©2013 Walgreen Co. All rights reserved.
Can we identify who is at risk?
Assessed the predictions made by• Physicians• Case managers• Nurses
“...none of the AUC values were statistically different from chance”
Allaudeen N, Schnipper JL, Orav EJ, Wachter RM, Vidyarthi AR. Inability of providers to predict unplanned readmissions. J Gen Intern Med. 2011;26(7):771-6
16©2013 Walgreen Co. All rights reserved.
Interventions to reduce readmissions
Systematic review of 43 studies identified three types of interventions:
• Pre-discharge• Post-discharge• Bridging
Hansen LO, Young RS, Hinami K, Leung A, Williams MV. Interventions to Reduce 30-Day Rehospitalization: A Systematic Review. Annals of Internal Medicine. Oct 18 2011;155(8):520-528.
17©2013 Walgreen Co. All rights reserved.
Brought toPharmacy
Picked up Are TakenProperly
First Refill
50% ‐ 70% 48% ‐ 60% 15% ‐ 20%100% 25% ‐ 30%
Prescriptions
Source: IMS
18©2013 Walgreen Co. All rights reserved.
Non-adherence: nearly 1 in 3 patients don’t fill
Burden Barriers
Burden & barriers of medication non-adherence
Clinical•Up to 25% of hospital admissions1
Financial•Estimated annual cost $290bn2
Humanistic•Approximately 342 Americans die every day1
•As many as 40% of patients3
RAND Review (2009)•Patient Factors
– Health beliefs– Cognition– Demographics– Disease burden– Medication characteristics
•Health System– Cost and managed care
•Provider– Trust and satisfaction– Communication
19
Prevalence
©2013 Walgreen Co. All rights reserved.
Source: Health Affairs: Medication Adherence Leads to Lower Healthcare Use and Costs Despite Increased Drug Spend
Impact of medication adherence
20©2013 Walgreen Co. All rights reserved.
Critical role of pharmacists in reducing unplanned readmissions•Reduction of 30-day post discharge hospital readmission or emergency department (ED) visit rates in high-risk elderly medical patients through delivery of a targeted care bundle. Journal of Hospital Medicine. 2009;4(4):211-218
•Implementation of an electronic system for medication reconciliation. American journal of health-system pharmacy AJHP : official journal of the American Society of Health-System Pharmacists. Feb 15 2007;64(4):404-422.
•Inpatient medication reconciliation at admission and discharge: A retrospective cohort study of age and other risk factors for medication discrepancies. The American Journal of Geriatric Pharmacotherapy. 2010;8(2):115-126.
Pharmacy intervention and proven outcomes
21©2013 Walgreen Co. All rights reserved.
• Provider visits• Ancillary health care services• ER visits• Hospital admissions• Pharmacy visits
Care transitions across patient/caregiver experience
22©2013 Walgreen Co. All rights reserved.
A simplified care continuum
Quality gaps in the care continuum result in poor health outcomes. Collaborative care coordination including
pharmacists can result in improved outcomes.23©2013 Walgreen Co. All rights reserved.
Care transitions collaboration
Aligned with health system core measuresFocused on reducing preventable readmissions
Coordinated effort to drive HCAHPS scores
Eligibility and Enrollment (WAG/HS)Medication History (WAG)
• 12 months, scrubbed• Clinician review
Med History Verification (HS)• ER/ED or Observation Unit• Inpatient
Discharge Planning Notification (HS)Bedside Delivery (WAG)
• Fill, Alignment, and Reconciliation• Pharmacist Consult
Post-Discharge Follow-Up (WAG/HS)
• Reinforce discharge instructions• Comprehensive medication reviews• Transition to Community Care• Interventions at 48h, 7-10d, and 25d
©2013 Walgreen Co. All rights reserved.
24
References
25
1. Fleming, W. (2008). Pharmacy management strategies for improving drug adherence. Journal of Managed Care Pharmacy, 14(6�b Supplement), S16�S20.
2. 2010 Benchmarks in improving medication adherence (2010, May). Healthcare Intelligence Network. Retrieved from http://store.hin.com/2010�Benchmarks�in�Improving�Medication�Adherence_p_4006.html.
3. Atreja, A., Bellam, N., & Levy, S. (2005). Strategies to enhance patient adherence: Making it simple. Medscape General Medicine, 7(1), 4.
4. Gellad WF, Grenard J, McGlynn EA. A Review of Barriers to Medication Adherence: A Framework for Driving Policy Options. RAND Health 2009. Available at: http://www.rand.org/content/dam/rand/pubs/technical_reports/2009/RAND_TR765.pdf
5. Peterson AM, Takiya L, Finley R. Meta-analysis of trials of interventions to improve medication adherence. Am J Health Syst Pharm. 2003 Apr 1;60(7):657-65.
6. Haynes RB, Ackloo E, Sahota N, et al. Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews. 2008(2).
©2013 Walgreen Co. All rights reserved.
References
7. Patel P, Zed PJ. Drug-related visits to the emergency department: how big is the problem? Pharmacotherapy. 2002 Jul;22(7):915-23.
8. Budnitz D.S., Pollock D.A., Mendelsohn A.B., Weidenbach K.N., McDonald A.K., Annest J.L. Emergency department visits for outpatient adverse drug events: Demonstration for a national surveillance system. Annals of Emergency Medicine. 2005;45(2):197-206.
9. Walgreens Dekalb HCAHPS data
10. Jack BW, Chetty VK, Anthony D, et.al. A reengineered hospital discharge program to decrease rehospitalization: a randomized trial. Ann Intern Med. 2009 Feb 3;150(3):178-87.
11. Dharmarajan K, Hsieh AF, Lin Z, et.al. Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia. JAMA. 2013 Jan 23;309(4):355-63.
12. Physician Visits After Hospital Discharge: Implications for Reducing Readmissions. Center for Studying Health System Change. NIHCR Research Brief No. 6. December 2011
13. IMS data
26©2013 Walgreen Co. All rights reserved.
Case Study: DeKalb Medical
27
Jacquelyn Paynter, R.N., M.P.H., C.C.M., Executive Director, Care Management, DeKalb Medical
©2013 Walgreen Co. All rights reserved.
3 hospital system in Metro Atlanta Region• 407 beds, 22,000 discharges, 65,000 ED visits, 4.6 ALOS• 100 bed, 5,800 discharges, 58,000 ED visits, 4.18 ALOS• 40 bed LTACHDPHO, mostly non-employed physiciansHospitalists – employedMajor factors impacting hospital utilization trends• Growing Uninsured populations• Health Care Reform PPACA Impact• Misalignment of financial incentives among healthcare providers• Fragmentation of health care delivery system
About DeKalb Medical
28©2013 Walgreen Co. All rights reserved.
Medicare All Cause All Hospital Readmission TrendFFY12 Q1 PEPPER Report – North Decatur
29©2013 Walgreen Co. All rights reserved.
Medicare All Cause All Hospital Readmission TrendFFY12 Q1 PEPPER Report - Hillandale
30©2013 Walgreen Co. All rights reserved.
•Recidivism Trends: Patients with 3 or more admissions in a 6 month period represent a high portion of the overall admission volume.
Jan-Jun 2012
Jan-Jun 2011
%CHG Frequent Admitters
%CHG Overall Volume
NORTH DECATUR
% Admissions by Frequent Admitters
14.1% 13.9% 1.7% -1.3%
%Frequently Admitted Patients
4.56% 4.53% 0.7% -1.6%
HILLANDALE
% Admissions by Frequent Admitters
12.4% 8.6% 44.2% 78.5%
% Frequently Admitted Patients
3.85% 2.56% 50.2% 69.0%
Readmission management imperatives
31©2013 Walgreen Co. All rights reserved.
Fiscal Year FFY2013 FFY2014 FFY2015
Targeted Conditions Heart Failure, AMI, Pneumonia
Heart Failure, AMI, Pneumonia
Heart Failure, AMI, Pneumonia COPD, CABG, PCI, Vascular Procedures
Aggregate payment withhold penalties
Up to 1% Up to 2% up to 3%
•Beginning October 1, 2012 (Federal Fiscal Year 2013), the Patient Protection and Affordable Care Act (PPACA) statute will penalize hospitals and integrated delivery systems with higher than expected readmission rates.
Readmission management imperatives
32©2013 Walgreen Co. All rights reserved.
Natl Avg Crude Rate
Eligible Discharges
Number of Readmissions
Predicted Risk Adjusted Hospital Rate
Expected Risk Adjusted National Rate
Excess Readmission
RatioNorth Decatur
AMI 19.2 109 25 22.1 21.6 1.0230HF 24.6 560 125 22.7 23.6 0.9636
CAP 18.5 494 79 16.6 17.6 0.9446Hillandale
AMI 19.2 23 3 20.3 21.1 0.9612HF 24.6 145 31 22.9 23.7 0.9645
CAP 18.5 95 25 19.0 16.6 1.1412
•CMS Hospital Compare
• FFY13 Pay for Performance Period: 7/1/08-6/30/11
P4P readmission management achievement
33©2013 Walgreen Co. All rights reserved.
•Readmission rates for the key MSDRG drivers are higher for patients discharged with no services.
DischargeDisposition
Digestive Disorders COPD Pneumonia Heart
Failure GI Bleed Renal Failure CVA Septicemia
GMLOS 2.8 4.7 5.3 5 4.9 5.1 5.3 5.4Average Age 72 71 73 75 74 69 77 77
Discharge Volume 125 101 153 271 113 112 70 318
% D/C w/ no services 87% 50% 56% 48% 54% 49% 23% 23%
% Readmissions D/C no services 90% 87% 74% 67% 66% 64% 63% 30%
Overall% Readmissions 12% 16% 10% 18% 12% 18% 7% 17%
Readmission management imperatives
34©2013 Walgreen Co. All rights reserved.
*pending implementation
ADMISSION ASSESSMENT Readmission Risk AssessmentED Case ManagementMedication Reconciliation
PATIENT/FAMILY EDUCATION Zone EducationWalgreens Bedside Rx Delivery and 72hr f/up callsVNHS Preferred Home Health Provider
HANDOVER COMMUNICATION Hospitalists fax discharge summary and medication reconciliation to PCPWalgreens Bedside Rx Delivery notified of pending dischargesCase Management provides an electronic discharge summary to post-acute providers (HHA,SNF,Dialysis)
DISCHARGE PLAN Walgreens Bedside Rx DeliveryMedication Reconciliation*Post Acute Services (HHA, DME, SNF, Dialysis, Hospice)
COMMUNITY CONNECTION VNHS Preferred Home Health Provider48-72hr Post-Discharge Calls – Dekalb Call Center and Walgreens RxPCP Follow-up AppointmentsPost-Discharge Transition Clinic*
Implementation of 5 care transition pillars at DeKalb Medical
35©2013 Walgreen Co. All rights reserved.
Care transition focus enhanced admission assessment
Incorporated a Readmission Risk Stratification Tool into the Discharge Planning Initial Assessment
Assessments are performed within 48 hours of admission
Key Readmission Risk Elements: Self care motivationReadmission historySeverity of illnessComorbiditiesHigh risk medicationsPolypharmacyCognitive and Self Care DeficitsPatient perception of reason for readmissionRecommended interventions for each risk assessment elementPilot Study – March-May 2012
Medication related causes had a high impact on readmission
36©2013 Walgreen Co. All rights reserved.
Care transition focus enhanced admission assessment
Social Workers staffed in the ED 11:30 a.m. to 8:00 p.m. 7 days/week
Key FunctionsDetermine appropriate level of care designationScreen for frequent fliers/recidivism Facilitate benefit counselor referralArrange PCP follow-up visits for P4P Readmission population (HF, PN, AMI, COPD)Facilitate PCP identification/referrals/assignmentProvide community resourcesProvide medication assistanceDischarge to post acute services from the ED where appropriateImplementation – September 2012
The hospital spends nearly $100K/year providing medication assistance
Establish Admission Review (ED) Case Management to enhance revenue cycle performance and reduce inappropriate readmissions
37©2013 Walgreen Co. All rights reserved.
Care transition focus patient education
Implemented ZONE Patient Education Model
Key Program ElementsPatient Education Process –Teach Back Method Implemented – 1st Quarter of 2010Provided by hospital nursing staff and Preferred Home Health Provider
38©2013 Walgreen Co. All rights reserved.
Care transition focus community connection
Home Health InterventionProvides Care Transitions focused program for HF, PN, COPDImplemented Zone Patient Education Model for consistency with hospitalOnsite Liaisons may attend Daily Unit-Based Huddles
Metric CY 2011 CY 2012Average HH referrals/month 192 244
Average HH admits/month 147 157
Hospital Median LOS 4.2 4.0
Readmission Rate 17% 15.4%
39©2013 Walgreen Co. All rights reserved.
Care transition focus community connection
Implemented Post Discharge Follow-up Calls 2400/2200 (May 2011)3200/3400 (September 2011)Hillandale and 4200/4400/4500 (January 2012)
Key FunctionsCall center places calls for all discharges 48 hours after discharge.Scripted calls to determine change in condition, barriers to medication compliance, and barriers to PCP follow-up, disease specific questionsScript prompts for call center staff to make a 3-way call to the PCP based on defined triggers Script prompts assistance with PCP identification and referrals Script includes customer satisfaction prompts
Recitivist Management – call center to support scripted outreach to targeted high risk recidivist – 2013
40©2013 Walgreen Co. All rights reserved.
Care transition focus community connection
Results: 2400 Telemetry Unit – January to June 2012
Call Center InterventionsPhysician Assistance 2%
Pharmacy Assistance 3%
Contact with Home Health 2%
Appointment Scheduling 3%
Call Responses90% call rate (n=300/month)51% contact rate 7% fall out for no PCP follow-up appointment8% fall out for not filling prescription12%fallout for prescribed home health follow-up91% felt they understood discharge instructions89% felt ready for discharge
41©2013 Walgreen Co. All rights reserved.
Care transition focus community connection
Results: 2400 Telemetry Unit – January to June 2012Patient response to heart failure prompts
"Signs you should contact a physician/HH"a) Increased shortness of breath 69%b) Increased swelling 69%d) Weight gain of more than 2lbs in 1 day, 5/week 62%
a) Weigh yourself each AM 69%b) Take medication as ordered 69%c) Check for swelling 69%d) Follow dietary restrictions 77%e) No smoking or drinking 69%f) Keep all physician appts. 77%
"Foods to avoid"a) Processed meat 64%b) Junk food 62%c) Canned vegetables 62%d) Other 0%
42©2013 Walgreen Co. All rights reserved.
Care transition focus discharge process
Implemented Walgreens Bedside Rx DeliveryNorth Decatur Campus (May 2011)Hillandale Campus (January 2012)
Key Functions• Ensures patient receives the medication upon discharge• Supports patient satisfaction with discharge experience• Pharmacy consultation provided, if needed• Caregiver included in consult• Reaffirms understanding of medication while patient still in healthcare
system• Immediate start of therapy on discharge• 15-30 minute turn-around time• Provides 30-day supply of medications• Ability to refill at any pharmacy of patients choice• Follow-up phone call from clinical pharmacist within 72 hours of
discharge
DeKalb is Among Highest Volume Bedside Delivery Programs in U.S., serving about 300 inpatients and100 outpatients monthly.
DeKalb is Among Highest Volume Bedside Delivery Programs in U.S., serving about 300 inpatients and100 outpatients monthly.
43©2013 Walgreen Co. All rights reserved.
• There is a high correlation between readmission and medications
• Accurate medical history and medication reconciliation and handover communication between care providers is paramount
• Timely post discharge follow-up by post acute providers, call center staff and pharmacists using structured patient/family education and compliance screening identifies medication related failures
• Bedside Rx Delivery reduces readmission rates and improves patient satisfaction
What we have learned
44©2013 Walgreen Co. All rights reserved.
Methodology and Outcomes
45
Heather Kirkham, MPH PhD, Manager, Clinical Outcomes & Analytics, Walgreens
©2013 Walgreen Co. All rights reserved.
Methods
46
Study Design•Retrospective cohort of census of all discharges •Controls from
• Hospital’s historic data • Contemporaneous matches from non-participating facility
(i.e., Hillandale campus compared to North Decatur campus)
Statistical Analysis•30-day readmission calculation based on CMS SAS code, though
Only 2-hospital system Not limited to Medicare population
•Multiple logistic regression, controlling for demographic and clinical variables
Lewis G, Paynter J. Pharmacy-Hospital Collaboration to Reduce Readmissions. Care Continuum Alliance Forum 12. Atlanta, GA: October 2012. Research approved by Dekalb Medical’s institutional review board (IRB) on April 25, 2012 (DM Protocol #040512).
©2013 Walgreen Co. All rights reserved.
47
VariableHistoric
HillandaleContemporaneous
HillandaleHistoric
North DecaturContemporaneous
North Decatur
Care Transition Program
North Decaturn (count of qualifying admits) 1516
30-day readmit (%, n) 5.6% 85
LOS (mean ± SD) 4.0 4.2
age > 65 (%, n) 29.3% 444
age (mean ± SD) 55.7 15.3
HF_case (%, n) 0.3% 5
AMI_case (%, n) 1.6% 24
PN_case (%, n) 1.72 26
Medicaid (%, n) 9.3% 141
Race: Other (%, n) 4.2% 64
Race: Black (%, n) 59.8% 907
Race: White (%, n) 36.0% 545
©2013 Walgreen Co. All rights reserved.
Descriptive statistics
Note. HF=Heart Failure; AMI=Acute Myocardial Infarction; PN=Pnuemonia; LOS=Length of Stay
48
VariableHistoric
HillandaleContemporaneous
HillandaleHistoric
North DecaturContemporaneous
North Decatur
Care Transition Program
North Decaturn (count of qualifying admits) 4232 7024 13283 19089 1516
30-day readmit (%, n) 9.5% 400 10.8% 757 10.6% 1408 11.5% 2191 5.6% 85
LOS (mean ± SD) 4.3 5.1 4.3 9.6 5.5 6.4 5.1 240.7 4.0 4.2
age > 65 (%, n) 30.8% 1305 31.3% 2197 41.1% 5459 41.8% 7988 29.3% 444
age (mean ± SD) 54.9 18.0 55.0 18.4 59.5 17.7 59.5 18.0 55.7 15.3
HF_case (%, n) 3.5% 148 2.1% 146 1.7% 227 1.1% 207 0.3% 5
AMI_case (%, n) 1.3% 56 1.1% 74 1.0% 130 1.4% 271 1.6% 24
PN_case (%, n) 4.87 206 4.2 295 3.52 468 3.65 696 1.72 26
Medicaid (%, n) 12.0% 509 12.8% 902 9.9% 1312 10.6% 2028 9.3% 141
Race: Other (%, n) 2.1% 90 1.3% 93 5.0% 669 5.5% 1040 4.2% 64
Race: Black (%, n) 92.3% 3908 92.8% 6521 62.1% 8242 63.1% 12038 59.8% 907
Race: White (%, n) 5.5% 234 5.8% 410 32.9% 4372 31.5% 6011 36.0% 545
©2013 Walgreen Co. All rights reserved.
Descriptive statistics
49
Comparison Groups Age < 65 Age ≥ 65 Total
Historic Hillandale 9.1% 10.2% 9.5%
Contemporaneous Hillandale 10.4% 11.6% 10.8%
Historic North Decatur 9.9% 11.6% 10.6%
Contemporaneous North Decatur 10.4% 13.0% 11.5%
Care Transition Program 5.8% 5.2% 5.6%
Total 9.9% 12.0% 10.7%
©2013 Walgreen Co. All rights reserved.
Readmission rates by age and intervention group
50
Independent variables and covariates OR 95% CI LL 95% CI UL pMale 0.948 0.891 1.007 .0849Age 65 + * 1.231 1.159 1.307 <.0001Medicaid * 1.346 1.232 1.47 <.0001Race (Reference Group: White) 0
Black * 1.184 1.103 1.271 <.0001Other 0.938 0.795 1.107 .4499
Month * 1.014 1.005 1.023 .0018LOS * 1.028 1.024 1.033 <.0001CMS Conditions (Principal Diagnosis HF, AMI, or PN)
Any of three 0.969 0.858 1.094 .6085HF * 1.546 1.263 1.892 <.0001AMI * 0.439 0.3 0.643 <.0001PN 0.922 0.784 1.084 .3233
Care Transition Program (compared to nonparticipants) 0.486 0.389 0.606 <.0001Comparison groups (Reference Group: Program Participants) 0
Historic Hillandale * 1.757 1.38 2.238 <.0001Contemporaneous Hillandale * 2.033 1.613 2.563 <.0001Historic North Decatur * 1.995 1.592 2.5 <.0001Contemporaneous North Decatur * 2.184 1.747 2.73 <.0001
* p<.01©2013 Walgreen Co. All rights reserved.
Unadjusted risk of readmission
51
Independent variables and covariates OR95% CI
LL95% CI
UL pMale 0.954 0.896 1.014 .1316Age 65 + * 1.302 1.221 1.389 <.0001Medicaid * 1.437 1.31 1.577 <.0001Race (Reference Group: White)
Black * 1.243 1.153 1.339 <.0001Other 0.896 0.757 1.061 .2019
Month * 1.019 1.01 1.029 <.0001LOS * 1.026 1.022 1.031 <.0001CMS Conditions (Reference: Without Condition)
HF * 1.554 1.267 1.905 <.0001AMI * 0.428 0.292 0.627 <.0001
Comparison Groups (Reference Group: Program Participants)Historic Hillandale * 1.572 1.232 2.005 .0003Contemporaneous Hillandale * 1.879 1.488 2.373 <.0001Historic North Decatur * 1.828 1.458 2.293 <.0001Contemporaneous North Decatur * 2.071 1.655 2.591 <.0001
* p<.01©2013 Walgreen Co. All rights reserved.
Adjusted risk of readmission
52
Comparison Groups(Reference Group: Program Participants) Adjusted Unadjusted
Historic Hillandale * 1.572 1.757Contemporaneous Hillandale * 1.879 2.033Historic North Decatur * 1.828 1.995Care Transition program participants 1.000 1.000
Risk of readmission: adjusted vs. unadjusted
* p<.01©2013 Walgreen Co. All rights reserved.
53
• At both hospitals, the readmission rates are trending higher, comparing the historic period (2010) to the current period (2011 –June 2012) among patients not provided bedside delivery.
• Adjusting for gender, age, race, length of stay, month of discharge, and CMS condition, all four control groups had greater likelihood of readmission (adjusted OR = 1.6 – 1.9) compared to the cohort of patients who received bedside delivery.
©2013 Walgreen Co. All rights reserved.
Key findings
54
• These preliminary results are not adjusted for comorbid conditions (secondary diagnosis and procedure codes).
• Lack of data about readmissions to other hospital systems.• Selection bias likely in contemporaneous North Decatur cohort;
therefore, it is important to consider range of impact compared across all control groups.
• Not all criteria in the CMS code could be applied (e.g., prior Medicare eligibility) and current analysis is not restricted to CMS conditions, so direct comparison to rates provided by CMS is cautioned.
©2013 Walgreen Co. All rights reserved.
Study limitations
55
Results of current analysis suggests that bedside delivery of medications may decrease risk of 30-day readmission.
•O’Dell and Kuckukarisan1 noted significantly lower readmissions for cardiac patient seen by a clinical pharmacists upon discharge compared to usual care (1.3% vs 9.1%; p = 0.04), but only for patients with severe angina.•In a randomized control trial2, a pharmacist intervention noted reduced 30-days readmissions compared to the control group (10.0% vs. 38.1%, p= 0.04), but the difference was not significant by 60-days (30.0% vs. 42.9%, p = 0.52).•The “RED” intervention3 noted significantly lower 30-day rates of combined of ER and hospitalization (IRR=0.695 [0.515, 0.937]) but not 30-day readmission alone (0.720 [0.445. 1.164]).
1. O'Dell KM, Kucukarslan SN. Impact of the clinical pharmacist on readmission in patients with acute coronary syndrome [abstract]. The Annals of pharmacotherapy. Sep 2005;39(9):1423-1427.
2. Koehler BE, Richter KM, Youngblood L, et al. Reduction of 30-day postdischarge hospital readmission or emergency department (ED) visit rates in high-risk elderly medical patients through delivery of a targeted care bundle. Journal of Hospital Medicine. 2009;4(4):211-218.
3. Jack BW, Chetty VK, Anthony D, et al. A reengineered hospital discharge program to decrease rehospitalization. Annals of internal medicine. Feb 3 2009;150(3):178-187.
©2013 Walgreen Co. All rights reserved.
Interpretation of findings
56
Future Research•Improve model by adding additional variables to adjust for comorbidities and stratifying •Consider assessing impact on readmission over longer periods (e.g., 90-day readmission)•Develop a hospital-specific, claims-based predictive risk model (PRM) •Evaluate and refine risk stratification tool for the DeKalb’s inpatient population
Implications for Clinical Care and Policy Change•Increased understanding of risk of readmission risk can assist clinical staff identify highest risk patients.•Ongoing assessment will help refine interventional components of bedside delivery program.•Ability to show positive impact of bedside delivery program will supported expansion of program to Hillandale site.
©2013 Walgreen Co. All rights reserved.
Implications for clinical care and future research
Q&A Discussion
57©2013 Walgreen Co. All rights reserved.
Any questions? Thank you!
58
Contact Information:
•Robert S. London, MD, National Medical Director, Walgreens; Email: [email protected]
•Katherine Heller, Pharm.D., Vice President, Clinical Solutions –Integrated Delivery Systems & Patient Services, Walgreens; Email: [email protected]
•Jacquelyn Paynter, R.N., M.P.H., C.C.M., Executive Director, Care Management, DeKalb Medical; Email: [email protected]
•Heather Kirkham, MPH PhD, Manager, Clinical Outcomes & Analytics, Walgreens; Email: [email protected]
©2013 Walgreen Co. All rights reserved.